Variation Biotechnologies (Us) Inc is categorized under Biological Products Manufacturers in Cambridge, MA and active since 2007.
Variation Biotechnologies (Us) Inc was established in 2007, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Biological Products Manufacturers business, which does work in the B2B market, and is classified as a Biological Products Manufacturers, under code number 325414 by the NAICS.
If you are seeking more information, feel free to contact Jeff Baxter at the company’s headquarters by writing to 245 First St # 1100, Cambridge, Massachusetts MA 02142 or by phoning (617) 830-3031. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Variation Biotechnologies (Us) Inc |
| Contact Person: | Jeff Baxter |
| Address: | 245 First St # 1100, Cambridge, Massachusetts 02142 |
| Phone Number: | (617) 830-3031 |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 2007 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biological Products Manufacturers |
| SIC Code: | 2836 |
| NAICS Code: | 325414 |
| Share This Business: |
Variation Biotechnologies (Us) Inc was started in 2007 to provide professional Biological Products Manufacturers under the SIC code 2836 and NAICS code 325414. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Jeff Baxter for inquiries that concern Variation Biotechnologies (Us) Inc by calling the company number (617) 830-3031, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Variation Biotechnologies (Us) Inc can be found at the coordinates 42.363558,-71.078818 as well as the street address 245 First St # 1100 in Cambridge, Massachusetts 02142.
For its online presence, you may visit Variation Biotechnologies (Us) Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.